NMNan Meng

Nan Meng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nan Meng has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Case report: Lateral medullary syndrome with eight-and-a-half syndromes

    by Chun Bm Zuo, Mingmin Bm Zhao, Lei Mm Zhao, Nan Mm Meng, Xing Mm Xing, Na Mm Li

    Rationale: Lateral medullary syndrome is caused by atherosclerosis or embolism of the vertebral artery and its branches or the posterior inferior cerebellar artery (PICA).The eight-and-a-half syndrome is a rare pontocerebellar nerve-ocular syndrome presenting as a one-and-a-half syndrome plus ipsilateral seventh cerebral nerve palsy. The dorsolateral medullary syndrome combined with the eight-and-a-half syndromes is even rarer, so it is important to recognize the features of the classical brainstem syndrome and the eight-and-a-half syndromes. Patient concerns: Most patients with dorsolateral medullary syndrome combined with eight-and-a-half syndromes have a good prognosis, with recovery occurring within a few weeks to a few months, although a few patients may take longer to recover. Diagnosis interventions: In the course of disease development, the patient developed dysarthria, dysphagia, hypothermia, ipsilateral Horner sign and ataxia. Computed tomography was performed which showed cerebral infarction in the left brainstem. Cranial diffusion-weighted imaging + magnetic resonance angiography showed acute infarction in the left cerebellar hemisphere, with a high probability of severe stenosis or occlusion in the intracranial and proximal segments of the basilar arteries. This supports the diagnosis of dorsolateral medullary syndrome. The patient’s limited adduction and abduction of the left eye and limited adduction of the right eye, combined with peripheral paralysis of the affected lateral nerve, supported the diagnosis of eight-and-a-half syndromes. The administration of antiplatelet and anti-ester fixation treatment can effectively improve the symptoms and shorten the course of the disease. Outcomes: After antiplatelet and anti-ester fixation treatment, the symptoms improved and the patient was discharged. Lessons: Dorsolateral medullary syndrome combined with eight-and-a-half syndromes is a rare clinical condition, and therefore more attention should be paid to the early diagnosis and treatment of such patients.


  • Open Access

    Association of triglyceride-glucose index with major depressive disorder: A cross-sectional study

    by Man Jin, Peiyuan Lv, Hao Liang, Zhenjie Teng, Chenyang Gao, Xueru Zhang, Aihua Ni, Xiaona Cui, Nan Meng, Litao Li

    The triglyceride-glucose (TyG) index has been proposed as a new marker for insulin resistance, which is associated with a risk of major depressive disorder (MDD). This study aims to explore whether the TyG index is correlated with MDD. In total, 321 patients with MDD and 325 non-MDD patients were included in the study. The presence of MDD was identified by trained clinical psychiatrists using the International Classification of Diseases 10th Revision. The TyG index was calculated as follows: Ln (fasting triglyceride [mg/dL] × fasting glucose [mg/dL]/2). The results revealed that the MDD group presented higher TyG index values than the non-MDD group (8.77 [8.34–9.17] vs 8.62 [8.18–9.01], P < .001). We also found significantly higher morbidity of MDD in the highest TyG index group than in the lower TyG index group (59.9% vs 41.4%, P < .001). Binary logistic regression revealed that TyG was an independent risk factor for MDD (odds ratio [OR] 1.750, 95% confidence interval: 1.284–2.384, P < .001). We further assessed the effect of TyG on depression in sex subgroups. The OR was 3.872 (OR 2.014, 95% confidence interval: 1.282–3.164, P = .002) for the subgroup of men. It is suggested that the TyG index could be closely associated with morbidity in MDD patients; thus, it may be a valuable marker for identifying MDD.


  • Open Access

    Astragaloside IV improves cognitive impairment caused by CCH via improve ROS and NLRP3 pathway by up-regulating the PGC1α/Nrf2 pathway

    by Nan Meng, Meixi Li, Jing Xu, Tianyuan Guan, Man Jin, Zhenjie Teng, Lei Zhao, Mingyue Fan, Hongyu Hao, Peiyuan Lv

    This study was conducted to elucidate the possible molecular mechanisms of neuroprotective effect of Astragaloside IV (As-IV) on animal models of Vascular Dementia . Oxidative damage and neuroinflammation play a key role in chronic cerebral hypoperfusion (CCH) and lead to a decline in cognitive function in animals. In the present study, Sprague Dawley (SD) rats were randomly divided into sham group, model group, As-IV20 group, and As-IV50 group, with 10 rats in each group. The Morris water maze (MWM) was used to evaluate the cognitive function of rats. The nitrogen-blue tetrazolium photoreduction method was employed to detect the levels of superoxide dismutase (SOD) in the hippocampal tissue homogenate. The bituric acid method was utilised to detect the malondialdehyde (MDA) levels. Western blotting was performed to evaluate the levels of stimulator of interferon genes (Sting), NOD-like receptor protein 3 (NLRP3),Caspase-1 and Peroxisome proliferator-activated receptor gamma co-activator-1α (PGC-1α),and transcription factors such as nuclear factor erythroid-derived factor-2 (Nrf2) in hippocampus tissues. The results indicate that As-IV supplementation significantly regulates the above changes. In addition, As-IV treatment effectively up-regulates the PGC-1α and Nrf2. Overall, our findings suggest that As-IV can effectively improve the cognitive impairment caused by CCH and oxidative damage. Furthermore, mitochondrial damage and inflammation against CCH may be attributed to the activation of the PGC-1α/Nrf2 signalling pathway to reduce ROS. This activation can reduce neuroinflammation caused by Sting/NLRP3/caspase1 pathway.